Although both primary tumors and metastases often accumulate MICA, MICB, and ULBP proteins [152], low or absent expression of NKG2D ligands represents a well-established strategy employed by leukemia cells for escaping the immune response [153,154]. The gene discussed is KLRK1; the disease is leukemia.